First Oral At Home Treatment For COVID-19 Seen To Reduce Death By 50%!


A German pharmaceutical company named, Merck & CO, announced on Friday, October 1, that findings from a recent study showed its experimental antiviral pill -- molnupiravir -- reduced hospitalizations and deaths by half in people who had recently been infected with COVID-19.

Apparently the company will also soon ask health officials around the world to authorize its use. If it's approved for use, molnupiravir, will become the first at home oral antiviral treatment for COVID - 19.


Sponsored Content

Sponsored Content